4Schneider GB, Benis KA, Flay NW, Ireland RA, Popoff SN: Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 1995;16:657–662.
5Hollis BW, Bikle DD: Vitamin D-binding protein and vitamin D in blacks and whites. N Engl J Med 2014;370:879–880.
6Nykjaer A, Fyfe JC, Kozyraki R, Leheste JR, Jacobsen C, Nielsen MS, et al: Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci USA 2001;98:13895–13900.
7Daiger SP, Schanfield MS, Cavalli-Sforza LL: Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci USA 1975;72:2076–2080.
8Gibbs PE, Dugaiczyk A: Origin of structural domains of the serum-albumin gene family and a predicted structure of the gene for vitamin D-binding protein. Mol Biol Evol 1987;4:364–379.
9Cooke NE, Willard HF, David EV, George DL: Direct regional assignment of the gene for vitamin D binding protein (Gc-globulin) to human chromosome 4q11-q13 and identification of an associated DNA polymorphism. Hum Genet 1986;73:225–229.
10Svasti J, Kurosky A, Bennett A, Bowman BH: Molecular basis for the three major forms of human serum vitamin D binding protein (group-specific component). Biochemistry 1979;18:1611–1617.
11Fu L, Borges CR, Rehder DS, Wong BY, Williams R, Carpenter TO, et al: Characterization of additional vitamin D binding protein variants. J Steroid Biochem Mol Biol 2016;159:54–59.
12White P, Cooke N: The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000;11:320–327.
13Gomme PT, Bertolini J: Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 2004;22:340–345.
14McLeod JF, Cooke NE: The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues. J Biol Chem 1989;264:21760–21769.
15Cooke NE, McLeod JF, Wang XK, Ray K: Vitamin D binding protein: genomic structure, functional domains, and mRNA expression in tissues. J Steroid Biochem Mol Biol 1991;40:787–793.
16Bhan I: Vitamin d binding protein and bone health. Int J Endocrinol 2014;2014:561214.
17Chun RF: New perspectives on the vitamin D binding protein. Cell Biochem Funct 2012;30:445–456.
18Delanghe JR, Speeckaert R, Speeckaert MM: Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab 2015;29:773–786.
19Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, et al: Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 1999;103:239–251.
20Yamamoto N, Homma S: Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci USA 1991;88:8539–8543.
21Lauridsen AL, Vestergaard P, Nexo E: Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 2001;47:753–756.
22Henderson CM, Lutsey PL, Misialek JR, Laha TJ, Selvin E, Eckfeldt JH, et al: Measurement by a novel LC-MS/MS methodology reveals similar serum concentrations of vitamin D-binding protein in blacks and whites. Clin Chem 2016;62:179–187.
23Bolland MJ, Grey AB, Ames RW, Horne AM, Mason BH, Wattie DJ, et al: Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clin Endocrinol (Oxf) 2007;67:259–264.
24Sollid ST, Hutchinson MY, Berg V, Fuskevag OM, Figenschau Y, Thorsby PM, et al: Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Eur J Endocrinol 2016;174:445–452.
25Pop LC, Shapses SA, Chang B, Sun W, Wang X: Vitamin D-binding protein in healthy pre- and postmenopausal women: relationship with estradiol concentrations. Endocr Pract 2015;21:936–942.
26Moller UK, Streym S, Jensen LT, Mosekilde L, Schoenmakers I, Nigdikar S, et al: Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study. Nutrients 2013;5:3470–3480.
27Bikle DD, Gee E, Halloran B, Haddad JG: Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984;74:1966–1971.
28Shoukry A, Bdeer Sel A, El-Sokkary RH: Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Mol Cell Biochem 2015;408:25–35.
29Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, et al: Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009;7:28.
30Ghafouri B, Carlsson A, Holmberg S, Thelin A, Tagesson C: Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study. BMC Musculoskelet Disord 2016;17:206.
31Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53–58.
32Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice
